Education
About Us
Working with TipRanks
Follow Us
RaySearch Laboratories AB Class B (SE:RAY.B)
:RAY.B
Earnings Data
Report Date
Apr 29, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
1.42Last Year’s EPS
1.66Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a broadly positive operational and commercial picture: record revenues, strong organic growth, improving profitability and cash position, significant clinical milestones and substantial AI adoption/use cases. Key negatives are material currency headwinds, a book-to-bill ratio below 1 and slower-than-desired traction for RayCare (partly tied to regulatory timing). Management expects margin improvement (target at least 25% for 2026) and a RayCare ramp in coming years, and has strengthened shareholder returns with a higher dividend and a 50% payout policy.Company Guidance
Record Q4 and Full-Year Net Sales
Q4 net sales SEK 375 million, +16% YoY (all-time high). Full-year 2025 net sales SEK 1.344 billion, +13% YoY; organic growth +19%.
Strong Organic Growth After Currency Adjustment
Q4 organic growth (adjusted for currency headwinds) would have been +28%. Support sales growth adjusted for currency in Q4 was +16% (reported +6%).
Improved Profitability and Cash Generation
Q4 operating profit SEK 92 million, +25% YoY, EBIT margin 24% (would have been 27% adjusted for currency losses). Full-year operating profit SEK 292 million, margin 22% (adjusted margin 26% excluding currency losses and nonrecurring items). Q4 cash flow improved to SEK 91 million; cash balance end 2025 SEK 407 million and no debt.
Growing Recurring Revenue Base
Recurring support revenue for full year SEK 524 million, representing 39% of total revenues (Q4 support revenue SEK 139 million, 37% of Q4 sales), strengthening business robustness.
Major Customer Wins and Platform Expansions
Notable orders/expansions in Q4: Greater Poland Cancer Center expanded to proton planning; University of Pennsylvania selected RayStation for proton therapy across three clinics; Universitätsklinikum Gießen und Marburg chose RayStation to replace Philips Pinnacle.
Clinical and Scientific Milestones
Royal Marsden performed first online adaptive treatment on a standard Elekta linac using RayStation; Southwest Florida Proton Center delivered first patient treatments using RayStation + RayCare with IBA Proton system; RaySearch-supported teams performed the world's first clinical proton arc treatments in 2025 (named a top-10 physics breakthrough by Physics World).
AI Adoption and Productivity Gains
Deep learning segmentation used on ~270,000 patients in 2025; deep learning planning produced ~7,000 clinical plans to date. Customer case (Iridium, Belgium) shows time savings: patient modeling -44% and plan generation -47%. AI also used to speed developer workflows.
Shareholder Returns and Policy Update
Board proposes dividend SEK 4.00 per share (up from SEK 3.00). New dividend policy from 2026 to distribute 50% of profit after tax, subject to capital needs and investments.
SE:RAY.B Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:RAY.B Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 12, 2026 | kr175.40 | kr168.40 | -3.99% |
Nov 07, 2025 | kr210.50 | kr256.50 | +21.85% |
Aug 08, 2025 | kr304.50 | kr300.50 | -1.31% |
May 09, 2025 | kr238.12 | kr311.39 | +30.77% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does RaySearch Laboratories AB Class B (SE:RAY.B) report earnings?
RaySearch Laboratories AB Class B (SE:RAY.B) is schdueled to report earning on Apr 29, 2026, Before Open (Confirmed).
What is RaySearch Laboratories AB Class B (SE:RAY.B) earnings time?
RaySearch Laboratories AB Class B (SE:RAY.B) earnings time is at Apr 29, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of RaySearch Laboratories AB Class B stock?
The P/E ratio of RaySearch Laboratories AB is N/A.
What is SE:RAY.B EPS forecast?
SE:RAY.B EPS forecast for the fiscal quarter 2026 (Q1) is 1.42.